rs1256146

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005956.4(MTHFD1):​c.2565+86G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.174 in 821,954 control chromosomes in the GnomAD database, including 13,510 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2360 hom., cov: 32)
Exomes 𝑓: 0.18 ( 11150 hom. )

Consequence

MTHFD1
NM_005956.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.218

Publications

22 publications found
Variant links:
Genes affected
MTHFD1 (HGNC:7432): (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1) This gene encodes a protein that possesses three distinct enzymatic activities, 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase. Each of these activities catalyzes one of three sequential reactions in the interconversion of 1-carbon derivatives of tetrahydrofolate, which are substrates for methionine, thymidylate, and de novo purine syntheses. The trifunctional enzymatic activities are conferred by two major domains, an aminoterminal portion containing the dehydrogenase and cyclohydrolase activities and a larger synthetase domain. [provided by RefSeq, Jul 2008]
ZBTB25 (HGNC:13112): (zinc finger and BTB domain containing 25) Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTHFD1NM_005956.4 linkc.2565+86G>A intron_variant Intron 25 of 27 ENST00000652337.1 NP_005947.3 P11586
MTHFD1NM_001364837.1 linkc.2565+86G>A intron_variant Intron 25 of 26 NP_001351766.1
ZBTB25NM_001304508.1 linkc.174-4309C>T intron_variant Intron 2 of 2 NP_001291437.1 G3V2K3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTHFD1ENST00000652337.1 linkc.2565+86G>A intron_variant Intron 25 of 27 NM_005956.4 ENSP00000498336.1 P11586

Frequencies

GnomAD3 genomes
AF:
0.170
AC:
25892
AN:
151948
Hom.:
2355
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.161
Gnomad AMI
AF:
0.121
Gnomad AMR
AF:
0.184
Gnomad ASJ
AF:
0.244
Gnomad EAS
AF:
0.104
Gnomad SAS
AF:
0.178
Gnomad FIN
AF:
0.0876
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.186
Gnomad OTH
AF:
0.199
GnomAD4 exome
AF:
0.175
AC:
117498
AN:
669888
Hom.:
11150
AF XY:
0.177
AC XY:
63225
AN XY:
357182
show subpopulations
African (AFR)
AF:
0.162
AC:
2814
AN:
17332
American (AMR)
AF:
0.178
AC:
6530
AN:
36616
Ashkenazi Jewish (ASJ)
AF:
0.248
AC:
5116
AN:
20588
East Asian (EAS)
AF:
0.0881
AC:
2859
AN:
32464
South Asian (SAS)
AF:
0.182
AC:
11885
AN:
65210
European-Finnish (FIN)
AF:
0.0957
AC:
4732
AN:
49430
Middle Eastern (MID)
AF:
0.254
AC:
1080
AN:
4246
European-Non Finnish (NFE)
AF:
0.186
AC:
76172
AN:
410002
Other (OTH)
AF:
0.186
AC:
6310
AN:
34000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
5370
10740
16110
21480
26850
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1068
2136
3204
4272
5340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.170
AC:
25908
AN:
152066
Hom.:
2360
Cov.:
32
AF XY:
0.166
AC XY:
12343
AN XY:
74332
show subpopulations
African (AFR)
AF:
0.161
AC:
6682
AN:
41468
American (AMR)
AF:
0.184
AC:
2811
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.244
AC:
847
AN:
3470
East Asian (EAS)
AF:
0.104
AC:
537
AN:
5172
South Asian (SAS)
AF:
0.178
AC:
854
AN:
4800
European-Finnish (FIN)
AF:
0.0876
AC:
927
AN:
10580
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.186
AC:
12643
AN:
67986
Other (OTH)
AF:
0.197
AC:
416
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1070
2140
3210
4280
5350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
288
576
864
1152
1440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.184
Hom.:
1612
Bravo
AF:
0.180
Asia WGS
AF:
0.150
AC:
521
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.1
DANN
Benign
0.41
PhyloP100
0.22
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1256146; hg19: chr14-64920665; COSMIC: COSV53700484; COSMIC: COSV53700484; API